Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease

Overview

Journal J Pediatr

Specialty Pediatrics

Date 2020 May 9

PMID 32381466

Citations 13

Authors

Toshifumi Yodoshi

Ana Catalina Arce-Clachar

Qin Sun

Lin Fei

Kristin Bramlage

Stavra A Xanthakos

Francisco Flores

Marialena Mouzaki

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the prevalence of renal impairment in a large cohort of youths with histologically confirmed nonalcoholic fatty liver disease (NAFLD), and to determine its association with liver disease severity.

Study Design: Clinical, laboratory, and histology data were collected retrospectively in a pediatric cohort with biopsy-confirmed NAFLD at a tertiary care center between 2010 and 2017. Histological NAFLD severity was scored using validated criteria. Glomerular filtration rate (GFR) was calculated and categorized as low (<90 mL/min/1.73 m), normal (90-136 mL/min/1.73 m), or high (>136 mL/min/1.73 m). Univariate and multivariate modeling were used to determine differences between the GFR groups and to control for confounders.

Results: The cohort comprised 179 patients (82% non-Hispanic; median age; 14 years; IQR, 12-16 years). One-third of the patients had abnormal renal function, including 36 (20%) with glomerular hyperfiltration and 26 (15%) with low GFR. In multivariable logistic regression, compared with normal GFR, hyperfiltration was independently associated with higher NAFLD activity score (aOR, 2.96; 95% CI, 1.49-5.87; P = .002), after adjusting for age, sex, ethnicity, obesity severity, presence of type 2 diabetes mellitus, and medications.

Conclusions: In this large cohort with histologically confirmed NAFLD, renal impairment was highly prevalent and associated with liver disease severity, independent of obesity severity. Screening patients with confirmed NAFLD for renal complication is recommended.

Citing Articles

Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population.

Dalbeni A, Garbin M, Zoncape M, Romeo S, Cattazzo F, Mantovani A Int J Mol Sci. 2023; 24(21).

PMID: 37958820 PMC: 10649990. DOI: 10.3390/ijms242115837.

Comparison of focal segmental glomerulosclerosis and other primary glomerulonephrites in terms of parameters of hepatic steatosis and metabolic syndrome.

Ozkan E, Gok M, Cetinkaya H, Kaplan M, Sahin G Int Urol Nephrol. 2023; 55(10):2557-2566.

PMID: 36905497 DOI: 10.1007/s11255-023-03536-x.

Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.

Su W, Chen M, Xiao L, Du S, Xue L, Feng R Front Public Health. 2022; 10:1047794.

PMID: 36420005 PMC: 9676964. DOI: 10.3389/fpubh.2022.1047794.

Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans.

Koo D, Lee M, Jung I, Moon S, Kwon H, Rhee E J Pers Med. 2022; 12(7).

PMID: 35887639 PMC: 9320347. DOI: 10.3390/jpm12071142.

Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease.

Mosca A, Mantovani A, Crudele A, Panera N, Comparcola D, De Vito R Front Pediatr. 2022; 10:917714.

PMID: 35733806 PMC: 9207333. DOI: 10.3389/fped.2022.917714.

References

Savino A, Pelliccia P, Giannini C, de Giorgis T, Cataldo I, Chiarelli F . Implications for kidney disease in obese children and adolescents. Pediatr Nephrol. 2011; 26(5):749-58. DOI: 10.1007/s00467-010-1659-y. View

Mallat S, Al Kattar S, Tanios B, Jurjus A . Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association. Curr Hypertens Rep. 2016; 18(10):74. DOI: 10.1007/s11906-016-0684-z. View

Brunt E, Kleiner D, Wilson L, Belt P, Neuschwander-Tetri B . Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011; 53(3):810-20. PMC: 3079483. DOI: 10.1002/hep.24127. View

Correia-Costa L, Azevedo A, Afonso A . Childhood Obesity and Impact on the Kidney. Nephron. 2018; 143(1):8-11. DOI: 10.1159/000492826. View

Palatini P . Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension. Nephrol Dial Transplant. 2012; 27(5):1708-14. DOI: 10.1093/ndt/gfs037. View

Nielsen S, Hove K, Dollerup J, Poulsen P, Christiansen J, Schmitz O . Losartan modifies glomerular hyperfiltration and insulin sensitivity in type 1 diabetes. Diabetes Obes Metab. 2002; 3(6):463-71. DOI: 10.1046/j.1463-1326.2001.00169.x. View

Musso G, Gambino R, Tabibian J, Ekstedt M, Kechagias S, Hamaguchi M . Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014; 11(7):e1001680. PMC: 4106719. DOI: 10.1371/journal.pmed.1001680. View

Schwartz G, Munoz A, Schneider M, Mak R, Kaskel F, Warady B . New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009; 20(3):629-37. PMC: 2653687. DOI: 10.1681/ASN.2008030287. View

Marcuccilli M, Chonchol M . NAFLD and Chronic Kidney Disease. Int J Mol Sci. 2016; 17(4):562. PMC: 4849018. DOI: 10.3390/ijms17040562. View

10.

Kelishadi R, Qorbani M, Assadi F, Motlagh M, Djalalinia S, Shahsavari A . Glomerular Hyperfiltration as Predictor of Cardiometabolic Risk Factors among Children and Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult-V Study. Int J Prev Med. 2018; 9:33. PMC: 5869957. DOI: 10.4103/ijpvm.IJPVM_38_18. View

11.

Yu J, Gupta G, Kang L, Bandyopadhyay D, Siddiqui M, Bhati C . Obesity does not significantly impact outcomes following simultaneous liver kidney transplantation: review of the UNOS database - a retrospective study. Transpl Int. 2018; 32(2):206-217. DOI: 10.1111/tri.13352. View

12.

Nitsch D, Felber Dietrich D, von Eckardstein A, Gaspoz J, Downs S, Leuenberger P . Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant. 2006; 21(4):935-44. DOI: 10.1093/ndt/gfk021. View

13.

Jadhakhan F, Marshall T, Gill P . A systematic review investigating the cumulative incidence of chronic kidney disease in young adults with impaired glucose tolerance. Syst Rev. 2015; 4:69. PMC: 4433064. DOI: 10.1186/s13643-015-0059-6. View

14.

Schmieder R, Messerli F, Garavaglia G, Nunez B . Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA. 1990; 264(21):2775-80. View

15.

Schwimmer J, Zepeda A, Newton K, Xanthakos S, Behling C, Hallinan E . Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease. PLoS One. 2014; 9(11):e112569. PMC: 4242611. DOI: 10.1371/journal.pone.0112569. View

16.

Brenner B, Lawler E, Mackenzie H . The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996; 49(6):1774-7. DOI: 10.1038/ki.1996.265. View

17.

Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G . A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017; 91(5):1224-1235. DOI: 10.1016/j.kint.2016.12.013. View

18.

Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6):2089-100. DOI: 10.1111/j.1523-1755.2005.00365.x. View

19.

Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

20.

Mathis K, Banks R . Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration. J Am Soc Nephrol. 1996; 7(1):105-12. DOI: 10.1681/ASN.V71105. View